PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Fluticasone propionate (Inhalation)
Presentation Product Chemical substance Chapter Items dispensed
Seretide 125 Evohaler
0302000N0BCAEBF
Seretide Fluticasone propionate (Inhalation) Respiratory System 94,475
Seretide 50 Evohaler
0302000N0BCADBE
Seretide Fluticasone propionate (Inhalation) Respiratory System 90,482
Seretide 250 Evohaler
0302000N0BCAFBG
Seretide Fluticasone propionate (Inhalation) Respiratory System 78,480
Seretide 500 Accuhaler
0302000N0BCACAZ
Seretide Fluticasone propionate (Inhalation) Respiratory System 62,555
Seretide 250 Accuhaler
0302000N0BCABAY
Seretide Fluticasone propionate (Inhalation) Respiratory System 56,946
Flutiform 125micrograms/dose / 5micrograms/dose inhaler
0302000N0BDAABJ
Flutiform Fluticasone propionate (Inhalation) Respiratory System 56,854
Flutiform 250micrograms/dose / 10micrograms/dose inhaler
0302000N0BDABBK
Flutiform Fluticasone propionate (Inhalation) Respiratory System 46,067
Sirdupla 25micrograms/dose / 125micrograms/dose inhaler
0302000N0BFAABF
Sirdupla Fluticasone propionate (Inhalation) Respiratory System 45,035
Sirdupla 25micrograms/dose / 250micrograms/dose inhaler
0302000N0BFABBG
Sirdupla Fluticasone propionate (Inhalation) Respiratory System 41,322
Seretide 100 Accuhaler
0302000N0BCAAAX
Seretide Fluticasone propionate (Inhalation) Respiratory System 38,424
Sereflo 25micrograms/dose / 250micrograms/dose inhaler
0302000N0BIABBG
Sereflo Fluticasone propionate (Inhalation) Respiratory System 31,375
Sereflo 25micrograms/dose / 125micrograms/dose inhaler
0302000N0BIAABF
Sereflo Fluticasone propionate (Inhalation) Respiratory System 29,844
Fluticasone 125mcg/dose / Salmeterol 25mcg/dose inh CFC free
0302000N0AABFBF
Fluticasone propionate (Inhalation) Fluticasone propionate (Inhalation) Respiratory System 23,802
Fluticasone 250mcg/dose / Salmeterol 25mcg/dose inh CFC free
0302000N0AABGBG
Fluticasone propionate (Inhalation) Fluticasone propionate (Inhalation) Respiratory System 20,688
Flutiform 50micrograms/dose / 5micrograms/dose inhaler
0302000N0BDACBL
Flutiform Fluticasone propionate (Inhalation) Respiratory System 20,430
AirFluSal 25micrograms/dose / 125micrograms/dose inhaler
0302000N0BGABBF
AirFluSal Fluticasone propionate (Inhalation) Respiratory System 18,525
Fluticasone 50microg / Salmeterol 25microg/dose inh CFC free
0302000N0AABEBE
Fluticasone propionate (Inhalation) Fluticasone propionate (Inhalation) Respiratory System 17,498
Combisal 25micrograms/dose / 125micrograms/dose inhaler
0302000N0BLABBF
Combisal Fluticasone propionate (Inhalation) Respiratory System 15,640
AirFluSal 25micrograms/dose / 250micrograms/dose inhaler
0302000N0BGACBG
AirFluSal Fluticasone propionate (Inhalation) Respiratory System 14,793
Fluticasone 50micrograms/dose inhaler CFC free
0302000N0AABHBH
Fluticasone propionate (Inhalation) Fluticasone propionate (Inhalation) Respiratory System 14,218
Fluticasone 125microg / Formoterol 5microg/dose inh CFC free
0302000N0AABJBJ
Fluticasone propionate (Inhalation) Fluticasone propionate (Inhalation) Respiratory System 13,955
Combisal 25micrograms/dose / 50micrograms/dose inhaler
0302000N0BLAABE
Combisal Fluticasone propionate (Inhalation) Respiratory System 12,957
Fluticasone 250microg / Formoterol 10microg/dose inh CFCfree
0302000N0AABKBK
Fluticasone propionate (Inhalation) Fluticasone propionate (Inhalation) Respiratory System 12,745
Combisal 25micrograms/dose / 250micrograms/dose inhaler
0302000N0BLACBG
Combisal Fluticasone propionate (Inhalation) Respiratory System 11,479
Fluticasone 125micrograms/dose inhaler CFC free
0302000N0AABABA
Fluticasone propionate (Inhalation) Fluticasone propionate (Inhalation) Respiratory System 10,964

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.